As a novel tau PET tracer in AD, [18F]MK-6240 has the potential in Down syndrome-associated Alzheimer’s disease (DSAD) to elucidate pathophysiology and advance diagnostic strategies. This evidence concerns the gene MAPT and Alzheimer disease.